INTERNATIONAL PATENT: SHANGHAI INSTITUTE OF INFECTIOUS DISEASES AND BIOSECURITY, 上海市重大传染病和生物安全研究院 FILES APPLICATION FOR "METABOLICALLY STABLE ANTI-DRUG-RESISTANT MAIN PROTEASE INHIBITOR AND USE THEREOF IN PREPARATION OF ANTIVIRAL DRUG"

GENEVA, Nov. 30 -- SHANGHAI INSTITUTE OF INFECTIOUS DISEASES AND BIOSECURITY (138 Yixueyuan RoadXuhui District, Shanghai 200032), 上海市重大传染病和生物安全研究院 (中国上海市徐汇区医学院路138号) filed a patent application (PCT/CN2025/096704) for "METABOLICALLY STABLE ANTI-DRUG-RESISTANT MAIN PROTEASE INHIBITOR AND USE THEREOF IN PREPARATION OF ANTIVIRAL DRUG" on May 23, 2025. With publication no. WO/2025/242188, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Class...